miR‑590‑5p targets RMND5A and promotes migration in pancreatic adenocarcinoma cell lines

Required for meiotic nuclear division 5 homolog A (RMND5A) functions as an E3 ubiquitin ligase. To date, few studies have investigated the role of RMND5A in cancer. In the present study, the expression levels of RMND5A in multiple types of cancer were analyzed using the Gene Expression Profiling Int...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology letters 2021-07, Vol.22 (1), p.1-532, Article 532
Hauptverfasser: Chen, Sixing, Chen, Yu, Wen, Yao, Cai, Wanwan, Zhu, Ping, Yuan, Wuzhou, Li, Yongqing, Fan, Xiongwei, Wan, Yongqi, Li, Fang, Zhuang, Jian, Jiang, Zhigang, Wu, Xiushan, Wang, Yuequn
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Required for meiotic nuclear division 5 homolog A (RMND5A) functions as an E3 ubiquitin ligase. To date, few studies have investigated the role of RMND5A in cancer. In the present study, the expression levels of RMND5A in multiple types of cancer were analyzed using the Gene Expression Profiling Interactive Analysis platform. The results revealed that RMND5A was highly expressed and associated with overall survival in patients with pancreatic adenocarcinoma (PAAD). A wound-healing assay revealed that RMND5A over-expression significantly increased cell migration in the PAAD cell lines AsPC-1 and PANC-1. In silico analysis predicted that RMND5A was a potential target of microRNA(miR)-590-5p. Further in vitro experiments demonstrated that overexpression of miR-590-5p downregulated the expression levels of RMND5A and decreased the migratory ability of the AsPC-1 and PANC-1 cell lines. In addition, overexpression of miR-590-5p attenuated the promoting effects of RMND5A on the migration of AsPC-1 and PANC-1 cells. The results of the present study may further elucidate the mechanisms underlying PAAD progression and provide novel targets for the treatment of PAAD. Key words: microRNA-590-5p, cell migration, pancreatic cancer, required for meiotic nuclear division 5 homolog A, prognosis
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2021.12793